Vetter aligns development service laboratory portfolio under one roof

3 Feb 2020

Bundling of competencies optimizes workflow of customer projects.

Vetter has brought together its development laboratories in one Ravensburg site end of last year.

Vetter aligns development service laboratory portfolio under one roof
Modern laboratory environment in the new 1,800-m2 building. (Picture source: Vetter Pharma International GmbH)

Designed to improve workflow and enhance customer benefits within the daily support in complex development projects, the services at the 1,800-m2 building include process development as well as functional and specification testing of packaging systems, chemical-analytical and biochemical analysis and particle characterization. State-of-the-art non-GMP laboratory space and equipment combined with a leading-edge GMP analytical laboratory now allow for increased capacity and optimized work spaces.

At present, more than 50 employees work in the new labs. By bringing the laboratories under one roof, employees easily share expertise and know-how to improve and simplify information exchange, leverage synergies and reinforce a positive work atmosphere. Overall, customers will benefit from the alignment. Prior to the bundling of its laboratories, the development studies and the corresponding analytical services for testing during process or packaging material development took place in several labs at different locations in Ravensburg and Langenargen. By sequencing these services, processes have been synchronized and handling issues reduced, all leading to numerous benefits primarily for customer projects, but also for projects undertaken within the company.

“Our customers are excited and impressed with the new and modern development laboratories and their increased capacity. Now they can follow a complete development process and its individual steps, since it proceeds throughout the labs, all within the same building,” said Dr Claus Feussner, Senior Vice President Development Service. Expansion will continue within the building throughout the year and includes additional lab space, innovative analytical equipment and lyophilizer capacity.

Vetter is also committed to further process optimization and capacity expansion in filling and secondary packaging of injectables at all its sites. This is based on increased global customer demand for the development and commercialization of promising new compounds.

Read More

Related news

Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

21 Feb 2020

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

Read more 
The game is on for connected devices

The game is on for connected devices

20 Feb 2020

Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.

Read more 
Management healthcare consultancy opens new offices in New York and London

Management healthcare consultancy opens new offices in New York and London

19 Feb 2020

The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.

Read more 
CPhI South East Asia rescheduled for July 2020

CPhI South East Asia rescheduled for July 2020

18 Feb 2020

Event move ensures extra precautions and safety measures taken

Read more 
Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics

Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics

18 Feb 2020

Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.

Read more 
Dr Reddy's to acquire Wockhardt divisions

Dr Reddy's to acquire Wockhardt divisions

18 Feb 2020

Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company

Read more 
Sartorius sharpens its brand focus

Sartorius sharpens its brand focus

17 Feb 2020

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

Read more 
FDA success for MedPharm Centre of Excellence

FDA success for MedPharm Centre of Excellence

14 Feb 2020

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

Read more 
Report predicts booming ASEAN generics export market for 2020

Report predicts booming ASEAN generics export market for 2020

13 Feb 2020

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Read more 
Partnership formed to deliver effective biopharma industry testing

Partnership formed to deliver effective biopharma industry testing

12 Feb 2020

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Read more